Department of Family Medicine, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Republic of Korea.
Supportive Care Center, Department of Family Medicine, Samsung Medical Center, Seoul, Republic of Korea.
JAMA Netw Open. 2021 Aug 2;4(8):e2120382. doi: 10.1001/jamanetworkopen.2021.20382.
Although total alcohol consumption is a known risk factor for gastrointestinal (GI) cancers, few studies have attempted to assess the pattern of alcohol drinking in association with GI cancers.
To evaluate the relative association of the frequency of drinking vs the amount of alcohol consumed per occasion with the development of GI cancers.
DESIGN, SETTING, AND PARTICIPANTS: A population-based retrospective cohort study used data from the Korean National Health Insurance System database on 11 737 467 participants without cancer who underwent a national health screening program from January 1, 2009, to December 31, 2010. Participants were followed up from the year after their health screening date until they received a diagnosis of GI cancer, death, or December 31, 2017. The median follow-up duration was 6.4 years (interquartile range, 6.4-7.4 years). Statistical analysis was performed from January 1, 2019, to March 31, 2020.
Weekly alcohol consumption (nondrinker [0 g/week], mild drinker [0-104 g/week], moderate drinker [105-209 g/week], and heavy drinker [≥210 g/week]), drinking frequency, and amount per occasion.
Incident GI cancers at 6 specific sites (esophagus, stomach, colorectal, liver, biliary, and pancreas).
Among 11 737 467 participants (6 124 776 women [52.2%]; mean [SD] age, 54.6 [10.4] years), 319 202 (2.7%) developed GI cancer. Compared with nondrinkers, the risk of GI cancer was higher for mild drinkers (adjusted hazard ratio [aHR], 1.04; 95% CI, 1.03-1.05), moderate drinkers (aHR, 1.14; 95% CI, 1.12-1.15), and heavy drinkers (aHR, 1.28; 95% CI, 1.26-1.29). The risk of GI cancer increased linearly with the frequency of drinking in a dose-dependent manner (aHR, 1.39; 95% CI, 1.36-1.41 for individuals who drink every day). In contrast, the risk of GI cancer appeared to increase with consumption up to 5 to 7 units per occasion (aHR, 1.15; 95% CI, 1.14-1.16), and then the HRs were no higher for those with a higher intake per session than 5 to 7 units (8-14 units per occasion: aHR, 1.11; 95% CI, 1.09-1.12; >14 units per occasion: aHR, 1.11; 95% CI, 1.08-1.14). Given similar weekly alcohol consumption levels, the risk of GI cancer increased with a higher frequency of drinking and decreased with a higher amount per occasion. Risk patterns for 6 specific cancers were generally similar to that of all GI cancers.
In this cohort study, frequent drinking was a more important risk factor for incident GI cancers than the amount of alcohol consumed per occasion. Individuals should be cautioned about regular consumption of small amounts of alcohol in addition to the total amount of alcohol consumption or amount per occasion.
尽管总饮酒量是胃肠道(GI)癌症的已知危险因素,但很少有研究试图评估与 GI 癌症相关的饮酒模式。
评估饮酒频率与每次饮酒量与 GI 癌症发展之间的相对关联。
设计、设置和参与者:本研究采用了韩国国家健康保险系统数据库中的一项基于人群的回顾性队列研究数据,该数据库纳入了 11737467 名未患癌症的参与者,他们参加了国家健康筛查计划,时间为 2009 年 1 月 1 日至 2010 年 12 月 31 日。参与者从健康筛查后的次年开始随访,直到他们被诊断为 GI 癌症、死亡或 2017 年 12 月 31 日。中位随访时间为 6.4 年(四分位距,6.4-7.4 年)。统计分析于 2019 年 1 月 1 日至 2020 年 3 月 31 日进行。
每周饮酒量(不饮酒者[0 克/周]、轻度饮酒者[0-104 克/周]、中度饮酒者[105-209 克/周]和重度饮酒者[≥210 克/周])、饮酒频率和每次饮酒量。
6 个特定部位(食管、胃、结直肠、肝、胆道和胰腺)的新发 GI 癌症。
在 11737467 名参与者(6124776 名女性[52.2%];平均[标准差]年龄,54.6[10.4]岁)中,319202 人(2.7%)发生了 GI 癌症。与不饮酒者相比,轻度饮酒者(调整后的危险比[aHR],1.04;95%置信区间[CI],1.03-1.05)、中度饮酒者(aHR,1.14;95%CI,1.12-1.15)和重度饮酒者(aHR,1.28;95%CI,1.26-1.29)发生 GI 癌症的风险更高。GI 癌症的风险与饮酒频率呈线性增加,呈剂量依赖性(每天饮酒者的 aHR,1.39;95%CI,1.36-1.41)。相反,GI 癌症的风险似乎随着每次饮酒量的增加而增加,直到 5 到 7 个单位(aHR,1.15;95%CI,1.14-1.16),然后每次摄入超过 5 到 7 个单位时,HR 不再更高(8-14 个单位/次:aHR,1.11;95%CI,1.09-1.12;>14 个单位/次:aHR,1.11;95%CI,1.08-1.14)。在每周饮酒量相似的情况下,GI 癌症的风险随着饮酒频率的增加而增加,随着每次饮酒量的增加而降低。6 种特定癌症的风险模式通常与所有 GI 癌症的风险模式相似。
在这项队列研究中,与每次饮酒量相比,频繁饮酒是 GI 癌症发病的更重要危险因素。除了总饮酒量或每次饮酒量外,还应告诫个人注意定期少量饮酒。